Novavax's New CEO Leads Vaccine Trial Success, and Big Layoffs Too

Novavax's New CEO Leads Vaccine Trial Success, and Big Layoffs Too

Source: 
Motley Fool
snippet: 
  • Novavax’s John C. Jacobs detailed his plan to cut costs and manage cash flow.
  • And Novavax’s combined vaccine candidate -- one that could stand out in a post-pandemic world -- is delivering promising trial results.